BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17668454)

  • 1. Search for new antagonist ligands for adenosine receptors from QSAR point of view. How close are we?
    González MP; Terán C; Teijeira M
    Med Res Rev; 2008 May; 28(3):329-71. PubMed ID: 17668454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structure activity relationships as useful tools for the design of new adenosine receptor ligands. 1. Agonist.
    González MP; Terán C; Teijeira M; Helguera AM
    Curr Med Chem; 2006; 13(19):2253-66. PubMed ID: 16918353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New pyrazolo[3,4-b]pyridones as selective A(1) adenosine receptor antagonists: synthesis, biological evaluation and molecular modelling studies.
    Fossa P; Pestarino M; Menozzi G; Mosti L; Schenone S; Ranise A; Bondavalli F; Trincavelli ML; Lucacchini A; Martini C
    Org Biomol Chem; 2005 Jun; 3(12):2262-70. PubMed ID: 16010360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility.
    Baraldi PG; Tabrizi MA; Gessi S; Borea PA
    Chem Rev; 2008 Jan; 108(1):238-63. PubMed ID: 18181659
    [No Abstract]   [Full Text] [Related]  

  • 5. 1,3-dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships.
    Fernández F; Caamaño O; Isabel Nieto M; López C; García-Mera X; Stefanachi A; Nicolotti O; Isabel Loza M; Brea J; Esteve C; Segarra V; Vidal B; Carotti A
    Bioorg Med Chem; 2009 May; 17(10):3618-29. PubMed ID: 19398343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into 2-phenylpyrazolo[1,5-a]pyrimidin-3-yl acetamides as peripheral benzodiazepine receptor ligands: synthesis, biological evaluation and 3D-QSAR investigation.
    Selleri S; Gratteri P; Costagli C; Bonaccini C; Costanzo A; Melani F; Guerrini G; Ciciani G; Costa B; Spinetti F; Martini C; Bruni F
    Bioorg Med Chem; 2005 Aug; 13(16):4821-34. PubMed ID: 15975799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR study on thiazole and thiadiazole analogues as antagonists for the adenosine A1 and A3 receptors.
    Borghini A; Pietra D; Domenichelli P; Bianucci AM
    Bioorg Med Chem; 2005 Sep; 13(18):5330-7. PubMed ID: 15990318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting kinase selectivity profiles using Free-Wilson QSAR analysis.
    Sciabola S; Stanton RV; Wittkopp S; Wildman S; Moshinsky D; Potluri S; Xi H
    J Chem Inf Model; 2008 Sep; 48(9):1851-67. PubMed ID: 18717582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor model.
    Tuccinardi T; Schenone S; Bondavalli F; Brullo C; Bruno O; Mosti L; Zizzari AT; Tintori C; Manetti F; Ciampi O; Trincavelli ML; Martini C; Martinelli A; Botta M
    ChemMedChem; 2008 Jun; 3(6):898-913. PubMed ID: 18338422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors.
    Giorgi I; Leonardi M; Pietra D; Biagi G; Borghini A; Massarelli I; Ciampi O; Bianucci AM
    Bioorg Med Chem; 2009 Mar; 17(5):1817-30. PubMed ID: 19230680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological studies and molecular modeling investigation of 1,3-dimethyl-2,4-dioxo-6-methyl-8-(substituted) 1,2,3,4-tetrahydro [1,2,4]-triazolo [3,4-f]-purines as potential adenosine receptor antagonists.
    Pastorin G; Bolcato C; Cacciari B; Kachler S; Klotz KN; Montopoli C; Moro S; Spalluto G
    Farmaco; 2005 Apr; 60(4):299-306. PubMed ID: 15848204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based homology modeling as a computational strategy to depict the pyrazolo-triazolo-pyrimidine antagonists binding site of the human adenosine A2A receptor.
    Michielan L; Bacilieri M; Schiesaro A; Bolcato C; Pastorin G; Spalluto G; Cacciari B; Klotz KN; Kaseda C; Moro S
    J Chem Inf Model; 2008 Feb; 48(2):350-63. PubMed ID: 18215030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholinesterase inhibitors from QSAR point of view: how close are we?
    Sharma A; Piplani P
    Cent Nerv Syst Agents Med Chem; 2013 Mar; 13(1):71-87. PubMed ID: 23013375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenylethyl-substituted pyrimido[2,1-f]purinediones and related compounds: structure-activity relationships as adenosine A(1) and A(2A) receptor ligands.
    Drabczyńska A; Müller CE; Schiedel A; Schumacher B; Karolak-Wojciechowska J; Fruziński A; Zobnina W; Yuzlenko O; Kieć-Kononowicz K
    Bioorg Med Chem; 2007 Nov; 15(22):6956-74. PubMed ID: 17827019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 2-aminothiazoles and their amide derivatives on human adenosine receptors. Lack of effect of 2-aminothiazoles as allosteric enhancers.
    Göblyös A; Santiago SN; Pietra D; Mulder-Krieger T; von Frijtag Drabbe Künzel J; Brussee J; Ijzerman AP
    Bioorg Med Chem; 2005 Mar; 13(6):2079-87. PubMed ID: 15727861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.
    Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Nieto MI; Rodríguez-Borges JE
    Bioorg Med Chem; 2009 Sep; 17(18):6755-60. PubMed ID: 19682912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the aryl substituent kind and distance from pyrimido[2,1-f]purindiones on the adenosine receptor selectivity and antagonistic properties.
    Drabczyńska A; Schumacher B; Müller CE; Karolak-Wojciechowska J; Michalak B; Pekala E; Kieć-Kononowicz K
    Eur J Med Chem; 2003 Apr; 38(4):397-402. PubMed ID: 12750027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophoric models and 3D QSAR studies of the adenosine receptor ligands.
    Tintori C; Manetti F; Botta M
    Curr Top Med Chem; 2010; 10(10):1019-35. PubMed ID: 20370655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of strong intramolecular N-H...N hydrogen bonds in determining the conformation of adenosine-receptor antagonists.
    Ferretti V; Pretto L; Tabrizi MA; Gilli P
    Acta Crystallogr B; 2006 Aug; 62(Pt 4):634-41. PubMed ID: 16840813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.